PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPLICATIONS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, giving promising developments across various medical and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA delivers a safer, far more reliable option for therapeutic use, specificall